Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.
Saved in:
| Title: | Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy. |
|---|---|
| Authors: | Sukocheva OA; Department of Hepatology, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia. olga.sukocheva@sa.gov.au., Neganova ME; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.; Arbuzov Institute of Organic and Physical Chemistry, Federal Research Center, Kazan Scientific Center, Russian Academy of Sciences, Kazan, 420088, Russian Federation., Aleksandrova Y; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.; Arbuzov Institute of Organic and Physical Chemistry, Federal Research Center, Kazan Scientific Center, Russian Academy of Sciences, Kazan, 420088, Russian Federation., Burcher JT; College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA., Chugunova E; Arbuzov Institute of Organic and Physical Chemistry, Federal Research Center, Kazan Scientific Center, Russian Academy of Sciences, Kazan, 420088, Russian Federation., Fan R; Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China., Tse E; Department of Hepatology, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia., Sethi G; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore., Bishayee A; College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA. abishayee@lecom.edu., Liu J; Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. jqliu2@outlook.com. |
| Source: | Cell communication and signaling : CCS [Cell Commun Signal] 2024 May 02; Vol. 22 (1), pp. 251. Date of Electronic Publication: 2024 May 02. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38698424 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sukocheva+OA%22">Sukocheva OA</searchLink>; Department of Hepatology, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia. olga.sukocheva@sa.gov.au.<br /><searchLink fieldCode="AU" term="%22Neganova+ME%22">Neganova ME</searchLink>; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.; Arbuzov Institute of Organic and Physical Chemistry, Federal Research Center, Kazan Scientific Center, Russian Academy of Sciences, Kazan, 420088, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Aleksandrova+Y%22">Aleksandrova Y</searchLink>; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.; Arbuzov Institute of Organic and Physical Chemistry, Federal Research Center, Kazan Scientific Center, Russian Academy of Sciences, Kazan, 420088, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Burcher+JT%22">Burcher JT</searchLink>; College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA.<br /><searchLink fieldCode="AU" term="%22Chugunova+E%22">Chugunova E</searchLink>; Arbuzov Institute of Organic and Physical Chemistry, Federal Research Center, Kazan Scientific Center, Russian Academy of Sciences, Kazan, 420088, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Fan+R%22">Fan R</searchLink>; Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.<br /><searchLink fieldCode="AU" term="%22Tse+E%22">Tse E</searchLink>; Department of Hepatology, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.<br /><searchLink fieldCode="AU" term="%22Sethi+G%22">Sethi G</searchLink>; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.<br /><searchLink fieldCode="AU" term="%22Bishayee+A%22">Bishayee A</searchLink>; College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA. abishayee@lecom.edu.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. jqliu2@outlook.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101170464%22">Cell communication and signaling : CCS</searchLink> [Cell Commun Signal] 2024 May 02; Vol. 22 (1), pp. 251. <i>Date of Electronic Publication: </i>2024 May 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101170464 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1478-811X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221478811X%22">1478811X </searchLink><i>NLM ISO Abbreviation: </i>Cell Commun Signal <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38698424 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12964-024-01626-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 251 Titles: – TitleFull: Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sukocheva OA – PersonEntity: Name: NameFull: Neganova ME – PersonEntity: Name: NameFull: Aleksandrova Y – PersonEntity: Name: NameFull: Burcher JT – PersonEntity: Name: NameFull: Chugunova E – PersonEntity: Name: NameFull: Fan R – PersonEntity: Name: NameFull: Tse E – PersonEntity: Name: NameFull: Sethi G – PersonEntity: Name: NameFull: Bishayee A – PersonEntity: Name: NameFull: Liu J IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 2024 May 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1478-811X Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: Cell communication and signaling : CCS Type: main |
| ResultId | 1 |
